Document:

<PAGE>

                                                                    Exhibit 10.2

                    PRODUCT DEVELOPMENT AND LICENSE AGREEMENT

THIS DEVELOPMENT AND LICENSE AGREEMENT (the "Agreement") is made as of February
6, 2004 (the "Effective Date"), by and between BCONNECTED SOFTWARE, INC., a
Delaware corporation, with its principal office located at 380 Interlocken
Crescent, Suite 770, Broomfield, Colorado 80021 ("bConnected") and TRAC MEDICAL
SOLUTIONS, INC., a New York corporation with its principal office located at
2165 Technology Drive, Schenectady, NY 12308 ("Trac Medical").

                                    RECITALS

         WHEREAS, bConnected has developed certain proprietary commerce,
collaboration and communication software solutions which enable bConnected's
customers to exchange documents and conduct business over the Internet with
vendors, suppliers, customers and other trading partners, which such software
solutions include without limitation the Document Viewer, Integrator, Process
Engine, and the Visual Modeling Tool;

         WHEREAS, Trac Medical is, among other things, a leader in the
electronic healthcare forms ("eDocuments") processing industry; and

         WHEREAS, bConnected and Trac Medical desire to enter into an agreement
for the development, production of, and support an enterprise version of Trac
Medical's proprietary electronic healthcare forms processing solution known as
CareCert(R), which will have the characteristics and functionality described
more fully in this Agreement.

         NOW, THEREFORE, in consideration of the mutual promises and
undertakings of the parties, and for other good and valuable consideration,
receipt of which is hereby acknowledged, bConnected and Trac Medical agree as
follows:

                                    AGREEMENT

1.       DEFINITIONS.

1.1      "AA Homecare" means the American Association for Homecare.

         1.2 "bConnected Customers" means those entities listed in Exhibit D, as
updated from time to time by bConnected during the Term, that are, or have been
customers of bConnected within the previous twelve (12) month rolling periods
during the Term and who are not Members.

         1.3 "bPIP Software" means bConnected's Business Process Integration
Platform computer software programs described in Exhibit A hereto, including
updates and new releases thereto provided to Trac Medical pursuant to this
Agreement, if any, and accompanying Documentation.

         1.4 "CareCert ES" means the enterprise version of the CareCert(R)
eDocuments processing solution, as specified in the response to the RFP
submitted by the parties [ * * * * ], to be developed by bConnected under this
Agreement and consisting of [ * * * * ] and providing at a minimum functionality
equivalent to that as provided by the CareCert Software as more particularly
defined in the Statement of Work.

         1.5 "CareCert Software" means Trac Medical's CareCert(R) electronic
forms processing computer software programs described in Exhibit B hereto,
including updates and new releases thereto provided to bConnected pursuant to
this Agreement, if any, and accompanying Documentation.

         1.6 "Confidential Information" means all information related to a
party's business, financial affairs or operations, including but not limited to
information related to business plans, technology, source code, product or
service Development Requirements, Specifications, Acceptance Criteria,
customers, pricing, techniques and methods, which is either marked or identified
as confidential or which the receiving party knew or reasonably should have
known, under the circumstances, was confidential.

         1.7 "Customer" means a person, company, or other legal entity (a)
licensed to use the CareCert Software or CareCert ES for its own internal
purposes and not for distribution to, or use on behalf of, others or (b) to whom
services are provided using the CareCert Software or CareCert ES.

         1.8 "Developments" means all Technology made, conceived or reduced to
practice by either Party or its employees in connection with the development of
CareCert ES under this Agreement and all tangible and intangible results and
items arising out of or constituting the results of the development of CareCert
ES, but excluding the [ * * * * ] or any portion thereof.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       1
<PAGE>

         1.9 "Documentation" means all information provided by a party to the
other party which describes the form, features or operation of its software and
which is contained in a tangible medium, such as written format, tape, magnetic
or other media.

         1.10 "Executable Code" means the fully compiled version of a software
program that can be executed by a computer and used by an end user without
further compilation.

         1.11 "HA Agreement" means the definitive agreement, entered into
concurrently with or subsequent to this Agreement, between Trac Medical,
bConnected and Homecare Association regarding the development and marketing of
CareCert ES to Members. The parties agree that execution of the HA Agreement is
an express condition precedent to bConnected's obligations under this Agreement.

         1.12 "Homecare Association" means Homecare Association LLC, a party to
the HA Agreement and a limited liability company organized by AA Homecare to
carry out the transaction contemplated by the HA Agreement.

         1.13 "Intellectual Property Rights" means all present and future
worldwide intellectual property rights, including without limitation,
copyrights, trademarks, service marks, trade secrets, know how, inventions,
patents, patent applications, moral rights and all other proprietary rights,
whether registered or unregistered.

         1.14 "Malicious Code" means a computer program or piece of computer
code intentionally created to impair or corrupt computing systems, software,
and/or computer networks, including, without limitation, any so-called "worms,"
"viruses," "back doors," "time bombs," "Trojan Horses," "drop dead devices," (as
these terms are commonly used in the computer software field), or other software
routines designed to permit unauthorized access, to disable or erase software,
hardware, or data, or to perform any other similar type of function.

         1.15 "Marks" means the trademarks and trade names of Trac Medical and
bConnected listed in Exhibit A.

         1.16 "Member" means a person, company, or other legal entity that is a
member of AA Homecare.

         1.17 "RFP" means the AA Homecare request for proposal.

         1.18 "Source Code" means the human-readable version of a software
program that can be compiled into Executable Code.

         1.19 "Specifications" means the technical and other specifications for
CareCert ES, as set forth in the Statement of Work.

         1.20 "Statement of Work" shall means the statement of work attached to
this Agreement as Exhibit B as further described in Section 2.1.

         1.21 "Technology" shall mean algorithms, concepts, data, designs,
developments, discoveries, inventions or innovations, whether or not patentable;
and object models and modeling tools, HTML code, know-how, methods, Executable
Code, Source Code, procedures, programs, techniques, text and web pages, whether
or not copyrightable.

         1.22 "Trac Medical Service" means Trac Medical's proprietary eDocument
service currently marketed under the name CareCert, as currently operational and
as may be modified, upgraded or otherwise improved in the future so long as it
continues to provide the core functionality currently offered, including without
limitation, any updated version of the such service using CareCert ES, as
described in this Agreement and the HA Agreement.

2. DEVELOPMENT EFFORT

         2.1 Statement of Work. bConnected has prepared the Statement of Work
attached to this Agreement as Exhibit B, mutually agreed to by the parties, that
outlines the requirements for development of CareCert ES, as set forth in the
response to the RFP submitted by the parties on November 14, 2003. The Statement
of Work sets forth the high level functional Specification of what will be built
with specific deliverables and timetable and the estimate for the total amount
of Professional Services Fees. The Statement of Work includes, without
limitation, the following: (a) development requirements and responsibilities of
each party (the "Development Requirements"), (b) major characteristics of
performance and functionality, technical requirements and technical
specifications of CareCert ES, (c) the procedures for testing (if any) CareCert
ES and the acceptance criteria for the acceptance of CareCert ES ("Acceptance
Criteria"), (d) target dates for completion of major milestones and (e) cost &
time estimates for each major milestone. The parties agree that the Statement of
Work shall automatically, without any further action by the parties, incorporate
the terms and conditions of this Agreement. The Statement of Work may be
modified, but only if such modification is in writing and signed by both
parties. In the event of any conflict between any terms of this Agreement and
the terms set forth in the Statement of Work, the terms of this Agreement shall
govern, unless specifically stated otherwise in the Statement of Work.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       2
<PAGE>

         2.2 Liaison. Upon the execution of the Agreement, the parties shall
commence the necessary interfacing to permit bConnected to immediately commence
development of CareCert ES. Each party agrees to appoint a principal point of
contact, identified in the Statement of Work as "Project Managers," to whom all
communications between the parties with respect to development of CareCert ES
shall be directed.

         2.3 Delivery of Trac Medical Property. Subject to Section 4.2, Trac
Medical shall deliver to bConnected such of its Trac Medical Property (as
defined below) as may be reasonably required by bConnected in order to enable it
to comply with its obligations as set forth in this Agreement, including all
necessary code and other design information related to the current version of
the CareCert Software, and any other materials or information related to the
CareCert Software and its operating system, as may be reasonably required by
bConnected in order to perform the development work required to [ * * * * ]

         2.4 Cooperation and Assistance. The parties will cooperate and assist
each other in connection with the development of CareCert ES. Such cooperation
and assistance will include, in addition to any duties or responsibilities of
the parties set forth in the Statement of Work, each party providing to the
other party in a timely manner all information reasonably necessary for the
other party to perform it obligations in connection with the development of
CareCert ES. In addition, Trac Medical shall provide the services of at least
one engineer with a high level of familiarity with the current version of the
CareCert Software overall design and specific code, and access to other Trac
Medical employees as may be reasonably required to assist bConnected in
connection with the development of CareCert ES.

         2.5 Development of CareCert ES. Subject to the terms and conditions of
this Agreement (including, without limitation payment of all applicable fees),
bConnected shall [ * * * * ] to develop and deliver CareCert ES in accordance
with the Statement of Work and the Specifications. CareCert ES shall be
delivered in such format and on such media as agreed to by the parties in the
Statement of Work. Subject to milestones set forth in the Statement of Work,
bConnected shall determine the manner and means of developing CareCert ES and
shall use its [ * * * * ] to meet any target dates set forth in the Statement of
Work; provided, however, that the target date for CareCert ES shall be extended
by one (1) day for each day of delay caused by failure of Trac Medical to
complete any of its prerequisite obligations in timely fashion. bConnected shall
have no liability for delays in the delivery of CareCert ES resulting from the
acts or omissions of Trac Medical, its agents or employees. Provided bConnected
uses its [ * * * * ] to timely develop and deliver CareCert ES in accordance
with the Statement of Work, Trac Medical acknowledges and agrees that any target
dates set forth in the Development Requirements are only estimates that may not
be obtainable and are subject to such changes as may be necessary or appropriate
during the course of the development as agreed to by the parties.

         2.6 Delivery; Acceptance.

              (a) Subject to the terms and conditions of this Agreement
(including, without limitation payment of all applicable fees that are not
disputed by Trac Medical in good faith), bConnected will deliver CareCert ES to
Trac Medical (a) in its entirety in Executable Code format and (b) in Source
Code format, excluding any Source Code for any bConnected Property (which shall
be governed by Section 11 of this Agreement). Trac Medical's access to the
Source Code prior to its acceptance of CareCert ES shall be limited solely to
the purpose of determining whether CareCert ES satisfies the Acceptance
Criteria. Upon completion of the milestones as set forth in the Statement of
Work, Trac Medical shall have the right to receive the Source Code to CareCert
ES, excluding any Source Code for any bConnected Property, for such acceptance
testing, and bConnected shall promptly deliver such Source Code to Trac Medical,
upon the reasonable request of Trac Medical's Project Manager. Trac Medical's
obligation to pay all applicable fees that are not disputed in good faith prior
to its receipt of such Source Code shall be limited to those fees which are
actually due and owing as of the date Trac Medical requests delivery of the
Source Code. In the event that CareCert ES fails to function during development
and neither Trac Medical nor bConnected can remedy the problem within a
reasonable time frame, then Trac Medical shall be entitled to review the bPIP
Source Code in the presence of the bConnected technical lead on the project on
the bConnected premises, at a time convenient to both parties. Trac Medical
acknowledges that at no time will Source Code to bConnected Property be
transferred to Trac Medical except as provided under Section 11 of this
Agreement and the Source Code Escrow Agreement between the parties.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       3
<PAGE>

              (b) Upon delivery of CareCert ES to Trac Medical, Trac Medical
shall have the right to review and test CareCert ES for a period of three (3)
weeks following Trac Medical's receipt thereof (the "Acceptance Period") to
determine whether CareCert ES operates substantially in accordance with the
Acceptance Criteria. If Trac Medical fails to notify bConnected of its rejection
of CareCert ES by the expiration of the Acceptance Period, or if CareCert ES
operates substantially in accordance with the Acceptance Criteria, then CareCert
ES will be deemed accepted upon the expiration of the Acceptance Period. If Trac
Medical determines that CareCert ES fails to operate substantially in accordance
with the Acceptance Criteria, Trac Medical will, prior to the expiration of the
Acceptance Period, provide to bConnected a written rejection notice specifying
its reasons for rejecting CareCert ES in sufficient detail to allow bConnected
to reproduce such failure, and bConnected will use its [ * * * * ] to remedy
the failure within three (3) weeks after receipt of such rejection notice. At
the end of such three (3) week period, bConnected will submit a corrected
version of CareCert ES to Trac Medical for further review pursuant to the terms
of this Section 2.6. The procedure in this Section 2.6 will be repeated with
respect to the corrected version of CareCert ES to determine whether CareCert ES
operates substantially in accordance with the Acceptance Criteria, unless and
until Trac Medical issues a final rejection of CareCert ES after rejecting
CareCert ES on at least two (2) prior occasions. If Trac Medical issues a final
rejection of CareCert ES pursuant to this Section 2.6, the parties will submit
the dispute to Homecare Association or AA Homecare for consultation with the
parties. The parties agree that an appropriate committee of at least five (5)
persons of AA Homecare will make the final decision regarding any dispute in
connection with the acceptance of the CareCert ES. Upon final acceptance of
CareCert ES, bConnected will promptly provide Trac Medical with one (1) copy of
the Source Code for Developments created by bConnected under this Agreement. In
the event CareCert ES, as delivered by bConnected does not satisfy the
Acceptance Criteria according to the foregoing procedures, Trac Medical shall
have the right to terminate this Agreement in accordance with Section 10.2(c).
Nothing herein shall confer jurisdiction upon Homecare Association or AA
Homecare with respect to the CareCert Software.

         2.7 Change Orders; Conflicts. In the event either party requires a
material change to the Development Requirements or Specifications, such party
will provide a written change order to the other for approval, specifying the
change requested (each a "Change Order"). Each party agrees that a Change Order
may necessitate a change in the target dates and fees due under this Agreement.
No Change Order will be binding upon either party until it is signed by the
authorized representatives of both parties. Each Change Order will be governed
by the terms and conditions of this Agreement. In the event of a conflict
between the terms and conditions of this Agreement and those of a Change Order,
the terms and conditions of this Agreement will control, unless specifically
stated otherwise in the Statement of Work or applicable Change Order.

3. OWNERSHIP.

         3.1 bConnected Property. bConnected shall own and retain all right,
title and interest in and to all Technology of bConnected in existence as of the
Effective Date, including without limitation the bPIP Software, and Technology
that bConnected creates during the Term, but independent of, this Agreement,
together with all Intellectual Property Rights therein or thereto ("bConnected
Property"). The bConnected Property includes any modifications, enhancements to
or derivative works of the bConnected Property made, conceived or reduced to
practice by bConnected or its employees during the Term ("bConnected
Derivatives"). Any [ * * * * ] created by bConnected specifically for use with [
* * * * ] shall be considered part of the [ * * * * ] and [ * * * * ] under
Section 4. Except as otherwise expressly provided in Section 4, Trac Medical
shall have no right in or to any bConnected Property or license under
bConnected's Intellectual Property Rights, implied or express.

         3.2 Trac Medical Property. Trac Medical shall own and retain all right,
title and interest in and to (i) all Technology of Trac Medical in existence as
of the Effective Date, including without limitation the CareCert Software, and
Technology that Trac Medical creates during the Term, but independent of, this
Agreement, together with all Intellectual Property Rights therein or thereto and
(ii) all Developments made, conceived or reduced to practice by bConnected or
Trac Medical or their employees in the course of performing any services under
this Agreement, together with all Intellectual Property Rights therein or
thereto (the "Trac Medical Property"). Except as otherwise expressly provided in
the Statement of Work, the Trac Medical Property includes any modifications,
enhancements to or derivative works of the Trac Medical Property made, conceived
or reduced to practice solely by Trac Medical or its employees during the Term
("Trac Medical Derivatives"). Any Trac Medical Derivatives necessary for use
with CareCert ES shall be considered part of the CareCert Software and licensed
to bConnected under Section 4. Except as otherwise expressly provided in Section
4, bConnected shall have no right in or to any Trac Medical Property or license
under Trac Medical's Intellectual Property Rights, implied or express.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       4
<PAGE>

         3.3 Assignment. Subject to the terms and conditions of this Agreement,
including the payment of all applicable fees which Trac Medical does not dispute
in good faith, bConnected hereby assigns to Trac Medical all of bConnected's
right, title, and interest in and to those Developments created by bConnected
under this Agreement, together with all Intellectual Property Rights therein or
thereto. bConnected agrees to execute such documents, render such assistance,
and take such other reasonable actions as Trac Medical may reasonably request,
at Trac Medical's expense, to apply for, register, perfect, confirm, and protect
Trac Medical's rights in such Developments.

4. LICENSES.

         4.1 Trac Medical License to bPIP Software and Developments. Subject to
the terms and conditions of this Agreement (including the restrictions set forth
in Section 4.4), bConnected grants to Trac Medical a perpetual, non-exclusive,
non-transferable (except as permitted in Section 14.3) license to:

              (a) reproduce and distribute copies of the bPIP Software and such
Developments as may be bConnected Property, in Executable Code only, as [ * * *
* ], directly to Customers pursuant to a Customer Agreement that satisfies the
requirements of Section 4.6 in the form mutually agreed to by the parties; and

              (b) use bConnected Property, in Executable Code form only, as [ *
* * * ] to provide application services directly to Customers pursuant to a
Customer Agreement that satisfies the requirements of Section 4.6 in the form
mutually agreed to by the parties.

         4.2 bConnected License to CareCert Software. Subject to the terms and
conditions of this Agreement, Trac Medical grants to bConnected a non-exclusive,
non-transferable (except as permitted under Section 14.3) license to:

              (a) use, reproduce, modify, and create derivative works of the
CareCert Software, in Source Code form, only as may be [ * * * * ] and to
otherwise [ * * * * ] with the [ * * * * ] and the [ * * * * ] to create
CareCert ES; and

              (b) market and promote the CareCert Software, in Executable Code
only, solely as integrated into CareCert ES, directly to the bConnected
Customers pursuant to a Sales Agreement (as defined below); and

              (c) use the CareCert Software, in Executable Code form only,
solely as integrated in CareCert ES to conduct demonstrations directly for the
bConnected Customers.

         4.3      Exclusivity.

              (a) During the [ * * * * ] and for [ * * * * ] after [ * * * * ],
or (ii) enter into a [ * * * * ] or any other [ * * * * ] with any [ * * * * ]
or [ * * * * ], as the case may be, pursuant to which such [ * * * * ] or [ * *
* * ], acting on behalf of such entity, will [ * * * * ] or technology
substantially [ * * * * ] for the purpose of [ * * * * ]. Nothing in this
Section 4.3 shall be construed to prevent either party from developing, using,
licensing or distributing (either directly or pursuant to an agreement wit a
third-party) any upgrade or modification to CareCert ES in order to (A) comply
with its obligations arising under Section 5 hereof, the HA Agreement or other
end user agreement or (B) otherwise maintain or enhance the functionality of
CareCert ES.

              (b) During the [ * * * * ] will have the [ * * * * ] to act as [ *
* * * ] to [ * * * * ]to the [ * * * * ]. [ * * * * ] will not, nor will it
permit any [ * * * * ] to, [ * * * * ] or provide [ * * * * ] using [ * * * * ]
to [ * * * * ] unless and until the parties execute a mutually agreed upon sales
representative or similar agreement ("Sales Agreement").

           4.4      Restrictions.

              (a) Trac Medical acknowledges that the bConnected Property and the
structure, organization, and Source Code thereof constitute valuable trade
secrets of bConnected. Accordingly, except as expressly permitted herein or as
otherwise authorized by bConnected in writing, Trac Medical will not, and will
not permit any third party to (a) modify, adapt, alter, translate, or create
derivative works from the bConnected Property; (b) sublicense, lease, rent,
loan, sell, distribute, make available or otherwise transfer the bConnected
Property to any third party, (c) reverse engineer, decompile, disassemble, or
otherwise attempt to derive the Source Code for the bConnected Property; or (d)
otherwise use or copy the bConnected Property except as expressly allowed under
Section 4.1.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       5
<PAGE>

              (b) bConnected acknowledges that the Trac Medical Property and the
structure, organization, and Source Code thereof constitute valuable trade
secrets of Trac Medical. Accordingly, except as expressly permitted herein or as
otherwise authorized by Trac Medical in writing, bConnected will not, and will
not permit any third party to (a) modify, adapt, alter, translate, or create
derivative works from the Trac Medical Property; (b) sublicense, lease, rent,
loan, sell, distribute, make available or otherwise transfer the Trac Medical
Property to any third party, (c) reverse engineer, decompile, disassemble, or
otherwise attempt to derive the Source Code for the Trac Medical Property; or
(d) otherwise use or copy the Trac Medical Property except as expressly allowed
under Section 4.2.

              (c) Trac Medical may distribute CareCert ES or provide application
services using CareCert ES to any entity [ * * * * ], pursuant to the Sales
Agreement which shall set forth the appropriate terms and conditions as well as
the [ * * * * ] in a form and [ * * * * ].

         4.5 Trademark License; Branding. Subject to the terms and conditions of
this Agreement, each party grants to the other a non-exclusive, non-transferable
(except as permitted under Section 14.3), royalty-free license to use and
reproduce the such party's Marks solely in connection with marketing, promotion
and demonstration of CareCert ES. Each party agrees to state in appropriate
places on all materials using the other party's Marks that such party's Marks
are trademarks of such party and to include the symbol (TM) or (R) as
appropriate. Each party grants no rights in its Marks other than those expressly
granted in this Section 4.5. The parties will market and distribute CareCert ES
as "CareCert ES," unless otherwise mutually agreed in writing. Each party agrees
not to take any action inconsistent with the ownership of the other party's
Marks. Neither party will adopt, use, or attempt to register any trademarks or
trade names that are confusingly similar to the other party's Marks or in such a
way as to create combination marks with the other party's Marks. Each Party will
provide the other party with samples of all products and materials that contain
the other party's Marks prior to their public use, distribution, or display for
such party's quality assurance purposes and will obtain the other party's
written approval before such use, distribution, or display. Upon request, each
party will modify or discontinue any use of the other party's Marks if such
party determines that such use does not comply with it's then-current trademark
usage policies and guidelines.

         4.6 Customer Agreements. Before distributing CareCert ES or providing
applications services using CareCert ES to a Customer, Trac Medical will enter
into a binding, written agreement with such Customer that contains terms no less
restrictive than those set forth in this Agreement. Trac Medical will enforce
each such agreement with at least the same degree of diligence that Trac Medical
uses to enforce similar agreements for its own products or other software
products that it distributes, but in no event less than reasonable efforts. Trac
Medical will promptly notify bConnected if Trac Medical becomes aware of any
material breach of any such agreement as such breach relates to the bPIP
Software. Upon the termination of any such agreement, Trac Medical will use
reasonable efforts to obtain from the Customer all copies of CareCert ES and
Documentation that contain bConnected Property in such Customer's possession or
control.

         4.7 Required Third Party Hardware and Software. Trac Medical and/or
Customers will be responsible for obtaining and maintaining all technology
necessary to enable CareCert ES, including without limitation, [ * * * * ]
(including those licenses set forth in Exhibit A [ * * * * ]. Trac Medical shall
not be responsible for any hardware or software licenses required by bConnected
in connection with the development of CareCert ES. In the event that Trac
Medical installs redundant servers for CareCert ES or other remote equipment or
requires services to support CareCert ES redundancy, these capital and operating
expenses shall be the sole responsibility of Trac Medical.

5. SUPPORT AND MAINTENANCE SERVICES.

         5.1 Subject to the terms and conditions of this Agreement, for a period
of [ * * * * ] beginning on date of the final delivery of CareCert ES to Trac
Medical in accordance with the performance objectives and specific deliverables
set out in the Statement of Work ("Initial Support Term"), bConnected shall
provide Trac Medical with those support and maintenance services for the bPIP
Software and the Developments described in Exhibit C attached hereto ("Support
Services").

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       6
<PAGE>

         5.2 Subject to the terms and conditions of this Agreement, including
without limitation Trac Medical's payment of all applicable Support Fees, for
the remainder of the Initial Term after the end of the Initial Support Term (the
"Subsequent Support Term"), Trac Medical will pay for and obtain Support
Services from bConnected and bConnected will provide the Support Services to
Trac Medical, in accordance with Section 6.5.

6. FEES; EXPENSES; PAYMENT.

         6.1 Setup and Integration Fee. Upon Trac Medical's receipt of at least
[ * * * * ] under the [ * * * * ], Trac Medical will pay bConnected [ * * * * ]
in the form of a [ * * * * ] development payment, which will be [ * * * * ].

6.2      Professional Services Fees.

              (a) Professional Services. During the Term, Trac Medical will pay
bConnected the professional services fee ("Professional Services Fee") for the
professional services related to the customized development work to be performed
by bConnected in the creation of CareCert ES in accordance with the Statement or
Work. The hourly rate for these professional services will be as described as [
* * * * ] set in Section 6.2(b) below. Trac Medical shall pay the Professional
Service Fee as set forth in this Section 6. bConnected hereby agrees to a cap on
the total amount of Professional Services Fees equal to [ * * * * ] of the
estimated total Professional Service Fees set forth in the Statement of Work.

              (b) Discounted Consulting for Professional Services. In connection
with the customization and installation and overall implementation of CareCert
ES for each Customer, if required, bConnected shall charge Professional Services
Fees directly to each Customer utilizing the [ * * * * ]. bConnected shall
charge Customer [ * * * * ] per hour [ * * * * ] for the installation and
optional customization of CareCert ES in a Customer's network. There shall be no
limit to the aggregate Professional Services Fees billable by bConnected
hereunder, however all Professional Services Fees will be pre-authorized by each
Customer. A formal project definition and scope document shall be provided prior
to project commencement for each Customer.

         6.3 License Fees.

              (a) Homecare Association License Fees. Pursuant to the terms of
this Agreement related to the HA Agreement, Trac Medical will pay to bConnected
a [ * * * * ] fee of [ * * * * ] ("License Fee") for the license of [ * * * * ]
as an [ * * * * ] as follows:

                   (i) [ * * * * ]. Trac Medical will pay bConnected
[ * * * * ] of the License Fee in the form of a [ * * * * ] in immediately
available funds, as funds [ * * * * ]. Notwithstanding anything in this
Agreement or the Statement or Work to the contrary, bConnected will have [ * * *
* ], or any portion thereof, for Trac Medical until bConnected has received from
Trac Medical an [ * * * * ]. Trac Medical acknowledges and agrees that (A) the [
* * * * ] set forth in Section 1 of the SOW in Exhibit B, [ * * * * ], and (B)
if and when bConnected has expended resources in an amount equal to the initial
[ * * * * ], bConnected will have [ * * * * ], or any portion thereof, for Trac
Medical [ * * * * ] in the amount equal to [ * * * * ].

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       7
<PAGE>

                (ii) [ * * * * ]. Trac Medical will pay bConnected a [ * * * * ]
portion of the License Fee in the amount of [ * * * * ] within [ * * * * ] in
accordance with Section 2.7.

                (iii) License Fees on Transactions. The balance of the License
Fees will be paid to bConnected on an ongoing basis, in amounts equal to a [ * *
* * ] rate of (1) [ * * * * ] of the [ * * * * ] from Customer's use of the [ *
* * * ] or [ * * * * ], less the [ * * * * ] by Trac Medical under the HA
Agreement [ * * * * ] during the period beginning upon the Effective Date and [
* * * * ] after acceptance ("Initial Payment Period"), and (2) [ * * * * ] of
the [ * * * * ] after the end of the Initial Payment Period. Such License Fees
will be payable by Trac Medical until Trac Medical has paid bConnected the
balance of the License Fee in an aggregate amount of [ * * * * ], [ * * * * ]
and the [ * * * * ]. During the Initial Term, in no event will [ * * * * ] , as
applicable, for each [ * * * * ] using the [ * * * * ] or [ * * * * ],
regardless of whether such [ * * * * ] was pre-purchased or otherwise
discounted. In contemplation of the possibility that Trac Medical may alter its
revenue model during the Term, if Trac Medical charges Customers for use of the
CareCert Software or CareCert ES or for services provided using the CareCert
Software or CareCert ES other than on a [ * * * * ] basis, then Trac Medical
will pay bConnected [ * * * * ] using the [ * * * * ] as set forth in this
Section.

         6.4 License Fee Exemption. The License Fees set forth in Section
6.3(a)(iii) above and the Support Fee requirements set forth in Section 6.5
below will not apply to any [ * * * * ] already using the [ * * * * ] prior to
execution of the [ * * * * ] as listed in Exhibit D ("Existing CareCert
Customers"), unless such [ * * * * ] to [ * * * * ], in which case both the
License Fees and Support Fees will apply in the same amounts and payment
structure as set out for HA Agreement Customers. License Fees and Support Fees
payable from revenues earned from Customers who commence using the CareCert
Software after execution of the HA Agreement, but before bConnected delivers
CareCert ES, will be earned by bConnected, but payment of such License Fees
shall be due to bConnected on delivery of CareCert ES, and such payment shall be
reconciled against the advance payment set out in Section 6.3(b) above.

         6.5 Support Fees. In consideration of the Support Services to be
performed by bConnected hereunder, Trac Medical shall pay bConnected [ * * * * ]
support and maintenance fee as outlined herein ("Support Fee"). Support Services
during the Initial Support Period will be provided by bConnected to Trac Medical
[ * * * * ]. During the entire Subsequent Support Term, Trac Medical shall pay
the Support Fee in [ * * * * ], calculated as [ * * * * ] of the [ * * * * ], on
[ * * * * ] from the [ * * * * ], from use or license by Customers of the [ * *
* * ] and [ * * * * ], and reconciled each quarter, to an [ * * * * ].

         6.6 bConnected Revenue Share. For each bConnected Customer that
executes a purchase, license, service or similar agreement with the Trac
Medical, Trac Medical will [ * * * * ] as set forth in the Sales Agreement.

         6.7 Costs and Expenses. Trac Medical shall reimburse bConnected for
reasonable travel, lodging and meal expenses, and such other costs and expenses
as bConnected may incur in connection with the acceptance testing. bConnected
will invoice Trac Medical on a periodic basis, no more frequently than monthly,
for costs and expenses due hereunder, and Trac Medical shall pay all amounts
invoiced within thirty (30) days of the invoice date. bConnected shall not incur
any reimbursable expenditures in excess of $250 without first obtaining the
written consent of Trac Medical.

        6.8 Payment Terms.

              (a) Except for [ * * * * ], Trac Medical shall pay bConnected all
[ * * * * ] within thirty (30) days after the end of each calendar quarter in
which [ * * * * ].

              (b) Trac Medical shall pay bConnected all [ * * * * ] thirty (30)
days after the end of each calendar quarter in which [ * * * * ].

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       8
<PAGE>

              (c) Except for or License Fees which are due as set forth in
Section 6.8(a) and 6.8(b), and Services Fees which are due as set forth in
Section 6.5, Trac Medical shall pay all amounts set forth on bConnected's
invoices in immediately available funds within thirty (30) days after the date
of invoice. All fees due hereunder are non-refundable (except as expressly
provided herein) and not contingent on any additional services or products to be
provided. All payments must be made in U.S. dollars. Outstanding balances shall
accrue interest at a rate equal to the lesser of one and one half percent (1
1/2%) per month and the maximum rate permitted by applicable law, from due date
until paid. All fees due hereunder are exclusive of, and Trac Medical shall pay,
all sales, use and other taxes, export and import fees, customs duties and
similar charges applicable to the transactions contemplated by this Agreement,
except for taxes based upon bConnected's net income. Trac Medical agrees to
indemnify and hold bConnected harmless from and against all claims, liabilities,
costs, expenses and penalties arising out of or related to Trac Medical's
failure to timely report or pay any such taxes, fees, duties or charges.

         6.9 Records. At all times during the Term, and for at least one (1)
year after the termination of this Agreement, Trac Medical will maintain at its
principal place of business complete and accurate records with respect to Trac
Medical's activities pursuant to this Agreement, including, without limitation,
all data needed for verification of amounts to be paid to bConnected under this
Agreement.

         6.10 Audits. bConnected will have the right, during normal business
hours and upon at least ten (10) days prior notice, to have an independent audit
firm selected by bConnected, and reasonably acceptable to Trac Medical, inspect
Trac Medical's facilities and audit Trac Medical's records relating to Trac
Medical's activities pursuant to this Agreement in order determine Trac
Medical's compliance with the terms and conditions of this Agreement, including,
without limitation, to verify (i) Trac Medical's compliance with the terms and
conditions of this Agreement, and (ii) that Trac Medical has paid bConnected the
correct amounts owed under this Agreement. The audit will be conducted at
bConnected's expense, unless the audit reveals an underpayment of five percent
(5%) or more in any month, in which case Trac Medical will reimburse bConnected
for all reasonable costs and expenses incurred in connection with such audit.
Trac Medical will promptly pay any amounts shown by any such audit to be owing
plus interest as set forth in Section 6.8. Any confidential or proprietary
information disclosed in the course of the audit will be subject to the
confidentiality provisions between Trac Medical and bConnected in this
Agreement.

7. WARRANTIES; DISCLAIMER.

         7.1 Mutual Warranties. Each party represents and warrants that:

              (a) it has full right, power, and authority to enter into this
Agreement, to perform its obligations and duties under this Agreement, and to
grant the licenses granted by it in this Agreement;

              (b) its execution, delivery, and performance of this Agreement
does not and will not conflict with, violate, or result in a breach of any other
agreement, judgment, order, stipulation, or decree by which such party is bound;

              (c) it will perform its obligations under this Agreement in a
workmanlike manner, in conformity with the professional standards for comparable
services in the industry and in compliance with this Agreement; and

              (d) respectively, the bConnected Property and the Trac Medical
Property will contain no Malicious Code at the time of delivery, and prior to
delivery each party will have taken reasonable precautions to ensure that the
bConnected Property and the Trac Medical Property are free of Malicious Code.

         7.2 Warranties to Deliverables. bConnected further represents and
warrants as follows: [ * * * * ] Notwithstanding anything else set forth in this
Agreement, Trac Medical's sole and exclusive remedy for breach of the warranties
provided by Section 7.2(a) shall be [ * * * * ]. In the event that Trac Medical
notifies bConnected during the Initial Support Period of any reproducible
failure of CareCert ES to conform to the warranty, in this Section 7.2(b) due to
an error in the bPIP Software or the Developments, Trac Medical's sole and
exclusive remedy will be that bConnected shall correct and repair any such error
in the bPIP Software and Developments that prevents CareCert ES from performing
in accordance with the provisions of this Agreement and in accordance with the
Statement of Work at no additional charge to Trac Medical.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       9
<PAGE>

         7.3 Disclaimer. EXCEPT FOR THE EXPRESS WARRANTIES SET FORTH IN SECTIONS
7.1 AND 7.2, THE BCONNECTED PROPERTY, THE TRAC MEDICAL PROPERTY AND ALL SERVICES
AND ARE PROVIDED UNDER THIS AGREEMENT "AS IS" WITHOUT REPRESENTATIONS OR
WARRANTIES OF ANY KIND AND EACH PARTY EXPRESSLY DISCLAIMS ALL OTHER WARRANTIES,
EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE
IMPLIED WARRANTIES OF MERCHANTABILITY, TITLE, FITNESS FOR A PARTICULAR PURPOSE,
AND ANY IMPLIED WARRANTIES ARISING OUT OF COURSE OF DEALING OR COURSE OF
PERFORMANCE. BCONNECTED DOES NOT WARRANT THAT THE BPIP SOFTWARE, THE
DEVELOPMENTS OR ANY SERVICES WILL MEET TRAC MEDICAL'S REQUIREMENTS, OR THAT THE
OPERATION OF THE BPIP SOFTWARE OR DEVELOPMENTS WILL BE UNINTERRUPTED, ERROR-FREE
OR SECURE.

8. INDEMNIFICATION.

         8.1 bConnected Indemnity Obligations. bConnected agrees to defend,
indemnify and hold harmless Trac Medical from and against any and all loss,
liability and expense (including reasonable attorneys' fees) suffered or
incurred by reason of any claims, proceedings or suits brought by a third party
against Trac Medical to the extent based on, arising out of or resulting from:
(a) any claim that the bPIP Software or Developments, when used in accordance
with such license granted in Section 4, infringes upon any U.S. patent,
copyright or trade secret rights of the third party, (b) the gross negligence or
willful misconduct of bConnected, its agents or employees in connection with the
performance of the development work hereunder, (c) bConnected's use of the Trac
Medical Deposit Materials (defined in Section 11.2(a)) or (d) [ * * * * ]. In
the event the bPIP Software or the Developments become, or in bConnected's
opinion is likely to become, the subject of a claim of infringement, bConnected
may, in addition to its obligations to defend, indemnify and hold Trac Medical
harmless, at its option and expense, (i) procure for Trac Medical the right to
continue using the bPIP Software and Developments as provided in Section 4, (ii)
replace or modify the bPIP Software and Developments, as applicable, so that
they becomes non-infringing, and remains functionally equivalent, or (iii)
terminate the license granted with respect to the bPIP Software and Developments
and refund to Trac Medical a pro-rated portion of all License Fees paid by Trac
Medical to bConnected pursuant to Section 6 of this Agreement up to an amount
not to exceed [ * * * * ]. Notwithstanding the foregoing, bConnected will have
no obligation under this Section 8.1(a) or otherwise with respect to any
infringement claim based upon (A) any use of bPIP Software or Developments not
in accordance with this Agreement, (B) any use of bPIP Software or Developments
in combination with other products, equipment, software or data not contemplated
by this Agreement, where use of the bPIP Software or Developments alone would
not have been infringing; or (C) any modification of the bPIP Software or
Developments by any person other than bConnected, unless authorized by
bConnected in writing. Notwithstanding the foregoing, bConnected will have no
obligations under Section 8.1(c) to the extent that the claim alleges that the
unmodified Trac Medical Deposit Materials infringes upon any U.S. patent,
copyright or trade secret rights of a third party.

         8.2 Trac Medical Indemnity Obligations. Trac Medical agrees to defend,
indemnify and hold harmless bConnected from and against any and all loss,
liability and expense (including reasonable attorneys' fees) suffered or
incurred by reason of any claims, proceedings or suits brought by a third party
against bConnected to the extent based on, arising out of or resulting from: (a)
any claim that the CareCert Software, when used in accordance with such license
granted in Section 4, infringes upon any U.S. patent, copyright or trade secret
rights of the third party, (b) the gross negligence or willful misconduct of
Trac Medical, its agents or employees in connection with the performance
hereunder or (c) Trac Medical's use of the bConnected Deposit Materials (defined
in Section 11.1(a)). In the event the CareCert Software becomes, or in Trac
Medical's opinion is likely to become, the subject of a claim of infringement,
Trac Medical may, at its option and expense, (i) procure for bConnected the
right to continue using the CareCert Software as provided in Section 4, (ii)
replace or modify the CareCert Software, as applicable, so that they becomes
non-infringing, and remains functionally equivalent, or (iii) terminate the
license granted with respect to the CareCert Software. Notwithstanding the
foregoing, Trac Medical will have no obligation under this Section 8.2(a) or
otherwise with respect to any infringement claim based upon (A) any use of
CareCert Software not in accordance with this Agreement, (B) any use of CareCert
Software in combination with other products, equipment, software or data, where
use of the CareCert Software alone would not have been infringing; or (C) any
modification of the CareCert Software by any person other than Trac Medical,
unless authorized by Trac Medical in writing. Notwithstanding the foregoing,
Trac Medical will have no obligations under Section 8.2(c) to the extent that
the claim alleges that the unmodified bConnected Deposit Materials infringes
upon any U.S. patent, copyright or trade secret rights of a third party.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       10
<PAGE>

         8.3 Indemnification Procedure. The indemnified party shall: (a) give
prompt notice of any claim for which indemnification is sought to the
indemnifying party; (b) grant sole control of the defense or settlement of the
claim or action to the indemnifying party (except that the indemnified party's
prior written approval will be required for any settlement that reasonably can
be expected to require a material affirmative obligation of or result in any
ongoing material liability to the indemnified party); and (c) provide reasonable
cooperation to the indemnifying party and, at the indemnifying party's request
and expense, assistance in the defense or settlement of the claim.
Notwithstanding the foregoing, the indemnification obligations hereunder shall
not be relieved hereunder for failure to do the foregoing, or delay with so
doing, unless the indemnifying party is prejudiced thereby. In addition, the
indemnified party may, at its own expense, participate in its defense of any
claim.

9. CONFIDENTIALITY.

         9.1 Obligations. Each party agrees that it will (a) not use the
Confidential Information of the other party for any purpose not expressly
permitted by this Agreement; (b) hold the other party's Confidential Information
in confidence using the same standard of care as it uses to protect its own
confidential information of a similar nature, but in no event less than
reasonable care; (c) not disclose the Confidential Information of the other to
any third party without the other's prior written consent, except as expressly
permitted under this Agreement; and (d) limit access to the other's Confidential
Information to those of its employees or agents having a need to know who are
bound by confidentiality obligations at least as restrictive as those set forth
herein. Notwithstanding the foregoing, (i) either party may make disclosures as
required or requested by a court of law or any governmental entity or agency,
including but not limited to disclosures required by the Securities and Exchange
Commission of the United States or any similar authority in any other country,
provided that such party provides the other with reasonable prior notice to
enable such party to seek confidential treatment of such information; and (ii)
either party may disclose the terms and conditions of this Agreement solely to
potential investors, acquisition partners and its legal counsel and accountants
solely in connection with appropriate due diligence investigations in connection
with a proposed financing or acquisition, provided that each such third party is
bound by confidentiality obligations at least as restrictive as those set forth
herein.

         9.2 Exclusions. The restrictions on the use and disclosure of
Confidential Information shall not apply to any Confidential Information, or
portion thereof, which (a) is or becomes publicly known through no act or
omission of the receiving party; (b) is lawfully received from a third party
without restriction on disclosure; (c) is already known by the receiving party
at the time it is disclosed by the disclosing party without confidentiality
restriction, as shown by the receiving party's written records; or (d) is
independently developed by the receiving party without reference to the
disclosing party's Confidential Information, as shown by the receiving party's
written records.

         9.3 Injunctive Relief. Each party acknowledges that a breach or
threatened breach of this Section 9 would cause irreparable harm to the
non-breaching party, the extent of which would be difficult to ascertain.
Accordingly, each party agrees that, in addition to any other remedies to which
a party may be legally entitled, the non-breaching party shall have the right,
notwithstanding Section 14.7 hereof, to seek immediate injunctive or other
equitable relief in the event of a breach of this Section 9 by the other party
or any of its employees or agents.

10. TERM AND TERMINATION.

         10.1 Term. Unless earlier terminated pursuant to Section 10.2, the term
of this Agreement shall commence on the Effective Date and shall continue for a
period of [ * * * * ] years (the "Initial Term"), and thereafter, shall
automatically renew for successive one (1) year renewal terms (each a "Renewal
Term"), unless either party provides the other party with written notice of its
intent not to renew at least ninety (90) days prior to the expiration of the
Initial Term or then-current Renewal Term. The Initial Term and the Renewal
Terms are collectively referred to as the "Term."

         10.2 Termination.

              (a) Either party may terminate the Agreement upon written notice
in the event (a) the other party makes any assignment for the benefit of
creditors or has any petition under bankruptcy law filed against it, which
petition is not dismissed within sixty (60) days of such filing, or has a
trustee or receiver appointed for its business or assets, or (b) the other party
is in material breach of any obligation under this Agreement, which default is
incapable of cure or which, being capable of cure, has not been cured within
thirty (30) days after receipt of notice of such default.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       11
<PAGE>

              (b) Notwithstanding the foregoing, bConnected may also terminate
the Agreement immediately upon written notice in the event Trac Medical fails to
pay any undisputed amounts payable hereunder within ten (10) business days after
receiving written notice from bConnected that payment is overdue.

              (c) Subject to the acceptance criteria set forth in the Statement
of Work and in Section 2.6 of this Agreement, Trac Medical shall have the right
to terminate this Agreement immediately upon written notice in the event that
bConnected fails to deliver CareCert ES in accordance with the Statement of Work
and bConnected does not cure such failure with thirty (30) days after receiving
written notice of such failure from Trac Medical. In the event Trac Medical
terminates this Agreement pursuant to the foregoing sentence, bConnected shall
refund to Trac Medical only (i) the [ * * * * ] and (ii) any [ * * * * ];
provided that such [ * * * * ].

         10.3 Effect of Termination. Upon the expiration or termination of this
Agreement, (a) each party shall return the other's Confidential Information in
its possession or control, (b) subject to Section 10.4 below, all licenses to
any bConnected Property other than those granted in Section 4.1 or Trac Medical
Property granted to a party hereunder will immediately terminate, and each party
shall promptly discontinue all use of the bConnected Property (other than
pursuant to Section 4.1) or Trac Medical Property, as applicable, erase all
copies thereof from it's computers, and return to the owner all other copies
thereof in its possession or control, (c) all amounts not disputed in good faith
that are owed by each party to the other party under this Agreement which
accrued before such termination or expiration will be immediately due and
payable and (d) bConnected shall deliver to Trac Medical the Source Code and
Executable Code for the Developments (other than any bConnected Property, which
shall be governed by Section 11 of this Agreement) completed up to the date of
termination and Trac Medical shall have all right, title and interest thereto,
provided that Trac Medical has paid all amounts owed to bConnected under this
Agreement not disputed by Trac Medical in good faith. Sections 1, 3, 4.1
(subject to Section 10.4), 4.3, 4.4, 6, 7.2, 7.3, 8, 9, 10, 11, 12, 13 and 14
will survive the expiration or termination of this Agreement for any reason.

         10.4 Notwithstanding anything to the contrary in this Agreement, the
licenses granted to Trac Medical by bConnected under Section 4.1 will survive
termination of this Agreement [ * * * * ] in accordance with Section 6, [ * * *
* ], and all other amounts not disputed by Trac Medical in good faith and Trac
Medical has not materially breached this Agreement at the time of termination.
Notwithstanding the foregoing, upon the termination of this Agreement by
bConnected for an uncured material breach by Trac Medical or pursuant to Section
8.1, the licenses to any bConnected Property granted to Trac Medical hereunder
will immediately terminate, and Trac Medical shall promptly discontinue all use
of the bConnected Property, erase all copies thereof from it's computers, and
return to bConnected all copies thereof in its possession or control.

         11. SOURCE CODE ESCROW.

         11.1 bConnected Escrow.

              (a) Deposit. Within thirty (30) days after final acceptance by
Trac Medical, bConnected shall place in escrow with a mutually acceptable escrow
agent ("bConnected Escrow Agent"), a copy of the [ * * * * ] for the [ * * * * ]
and [ * * * * ] (collectively referred to as the "bConnected Deposit Materials")
bConnected shall enter into an escrow agreement with the bConnected Escrow
Agent, the form of which is set forth at Exhibit E to this Agreement,
identifying Trac Medical as a beneficiary thereunder ("bConnected Escrow
Agreement"). On a quarterly basis during the Term after the initial deposit,
bConnected shall deposit with the bConnected Escrow Agent any upgrades to the
bConnected Deposit Materials released during the previous fiscal quarter.

              (b) Release. The bConnected Escrow Agreement shall provide Trac
Medical with the right to obtain a copy of the bConnected Deposit Materials in
the event that, during the Term, bConnected:

                     (i) is [ * * * * ] under this Agreement;

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       12
<PAGE>

                (ii) [ * * * * ] under this Agreement;

                (iii) [ * * * * ]; or

                (iv) determines to [ * * * * ] set forth in this Agreement.

              (c) License. Upon release of the bConnected Deposit Materials to
Trac Medical, bConnected grants Trac Medical a [ * * * * ] (unless Trac Medical
commits a material breach of this Agreement), personal, nontransferable,
nonexclusive right and license to use the bConnected Deposit Materials [ * * * *
] (either directly or through a third-party that is subject to the limitations
contained herein) the [ * * * * ], as existing on the date of release from
escrow, solely for the benefit of [ * * * * ] who have properly licensed the use
of the [ * * * * ] and subject to the restrictions set forth in this Agreement.

              (d) Restrictions. The original and all copies of the bConnected
Deposit Materials, in whole or in part, are Confidential Information and are the
exclusive property of bConnected or its licensors, and shall be treated as such
by Trac Medical during or after the Term of this Agreement. Nothing herein,
however, shall be deemed as a grant or a license by bConnected to Trac Medical
to create, or have created for its benefit, any derivative works based on the
bConnected Deposit Materials other than to create or have created for the
benefit of Customers from the bConnected Deposit Materials any (A) necessary
fixes, patches and similar error corrections or (B) modifications to permit
CareCert ES to process eDocuments that have been amended by the appropriate
regulatory body.

           11.2     Trac Medical Escrow.

              (a) Deposit. Within sixty (60) days after the Effective Date, Trac
Medical shall place in escrow with a mutually acceptable escrow agent ("Trac
Medical Escrow Agent"), a copy of (i) the [ * * * * ] and the documentation
pertaining to such source code and (ii) the executable code only (and related
documentation) for software for the [ * * * * ] (the computer code and
documentation referred to in clauses (i) and (ii) shall be collectively referred
to as the "Trac Medical Deposit Materials") Trac Medical shall enter into an
escrow agreement with the Trac Medical Escrow Agent, the form of which is set
forth at Exhibit F to this Agreement, identifying bConnected as a beneficiary
thereunder ("Trac Medical Escrow Agreement"). On a quarterly basis during the
Term, Trac Medical shall deposit with the Trac Medical Escrow Agent any upgrades
to the Trac Medical Deposit Materials released during the previous fiscal
quarter.

              (b) Release. The Trac Medical Escrow Agreement shall provide
bConnected with the right to obtain a copy of the Trac Medical Deposit Materials
in the event that, during the Term, Trac Medical:

                (i)    [ * * * * ] under this Agreement;

                (ii)   [ * * * * ] under this Agreement;

                (iii)  [ * * * * ];

                (iv)   [ * * * * ]; or

                (v)    [ * * * * ] in this Agreement.

              (c) License. Upon release of the Trac Medical Deposit Materials to
bConnected, Trac Medical grants bConnected a [ * * * * ] (unless bConnected
commits a material breach of this Agreement), personal, nontransferable,
nonexclusive right and license to use the Trac Medical Deposit Materials
referred to in Section 11.2(a)(i) to [ * * * * ] (either directly or through a
third-party that is subject to the limitations contained herein) the [ * * * *
], as existing on the date of release from escrow, solely for the benefit of [ *
* * * ] who have properly licensed the [ * * * * ] and subject to the
restrictions set forth in this Agreement and (ii) to otherwise use the Trac
Medical Deposit Materials solely for the purpose of [ * * * * ].

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       13
<PAGE>

              (d) Restrictions. In the event the Trac Medical Deposit Materials
are released from escrow, bConnected acknowledges and agrees that its use of the
Trac Medical Deposit Materials referred to in Section 3.4(a)(ii) is subject to
any additional license agreement required by the licensor of such other Trac
Medical Deposit Materials. The original and all copies of the Trac Medical
Deposit Materials, in whole or in part, are Confidential Information and are the
exclusive property of Trac Medical or its licensors, and shall be treated as
such by bConnected during or after the Term of this Agreement. Nothing herein,
however, shall be deemed as a grant or a license by Trac Medical to bConnected
to create, or have created for its benefit, any derivative works based on the
Trac Medical Deposit Materials other than to create or have created for the
benefit of Customers from the Trac Medical Deposit Materials referred to in
Section 3.4(a)(i) any (A) necessary fixes, patches and similar error corrections
or (B) modifications to permit CareCert ES to process eDocuments that have been
amended by the appropriate regulatory body.

         11.3 Provision of [ * * * * ]. In the event that bConnected
obtains the Trac Medical Deposit Materials under Section 11.2, [ * * * * ].

         12. LIMITATION OF LIABILITY. EXCEPT FOR LIABILITY ARISING OUT OF A
BREACH BY EITHER PARTY OF SECTION 9 (CONFIDENTIALITY), OR LIABILITY ARISING OUT
OF OBLIGATIONS UNDER SECTION 8 (INDEMNIFICATION) IN NO EVENT WILL EITHER PARTY
BE LIABLE FOR ANY CONSEQUENTIAL, INDIRECT, EXEMPLARY, SPECIAL OR INCIDENTAL
DAMAGES, INCLUDING ANY LOST DATA OR LOST PROFITS OR COSTS OF PROCUREMENT OF
SUBSTITUTE GOODS OR SERVICES, ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE
USE OF OR INABILITY TO USE CARECERT ES OR ANY SERVICES PROVIDED HEREUNDER, EVEN
IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. EXCEPT FOR LIABILITY ARISING OUT
OF EITHER PARTY'S OBLIGATIONS UNDER SECTION 8 (INDEMNIFICATION), OR LIABILITY
ARISING OUT OF OBLIGATIONS UNDER SECTION 9 (CONFIDENTIALITY), IN NO EVENT WILL
EITHER PARTY'S TOTAL CUMULATIVE LIABILITY ARISING OUT OF OR RELATING TO THIS
AGREEMENT, THE USE OF OR INABILITY TO USE CARECERT ES OR ANY SERVICES PROVIDED
HEREUNDER, REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT OR
OTHERWISE, EXCEED [ * * * * ] .

         13. MUTUAL NON-SOLICITATION. Neither party shall, during the Term, and
for one (1) year thereafter, directly or indirectly hire or attempt to hire any
employee of the other party who performed substantial work on any project
covered by this Agreement without such other party's prior written consent;
provided that the foregoing shall not prohibit either party from issuing
advertisements of a general nature not specifically directed at any such
employee and hiring any such employee so long as such party is in compliance
with this Section 13.

14. GENERAL.

         14.1 Governing Law. This Agreement shall be governed by the laws of the
State of Colorado, without regard to its principles of conflicts of law. The
parties expressly exclude the application of the 1980 United Nations Convention
on the International Sale of Goods.

         14.2 Relationship of Parties. The relationship of the parties
established under this Agreement is that of independent contractors and neither
party is a partner, employee, agent or joint venture partner of or with the
other, and neither party has the right or authority to assume or create any
obligation on behalf of the other party.

         14.3 Assignment. Neither party may assign its rights or delegate its
obligations under this Agreement without the prior written consent of the other
party, which consent shall not be unreasonably withheld or delayed.
Notwithstanding the foregoing, either party may assign its rights and
obligations under this Agreement, without consent, to a parent or subsidiary or
to a successor (other than a competitor of the other party), whether by way of
merger, sale of all or substantially all of its assets or otherwise. Any
attempted assignment of this Agreement not in accordance with this subsection
shall be null and void.

         14.4 Notices. Any notices or other communications required or permitted
to be given or delivered hereunder shall be in writing and shall be delivered
personally, by courier service, by facsimile machine or by registered or
certified mail, return receipt requested, postage pre-paid, to bConnected and to
Trac Medical as follows:

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       14
<PAGE>

                  If to Trac Medical:

                           Trac Medical Solutions, Inc.
                           Attn:  CEO
                           2165 Technology Drive
                           Schenectady, NY  12308

                  If to bConnected:

                           bConnected Software, Inc.
                           Attn: President and CEO
                           380 Interlocken Crescent, Suite 770
                           Broomfield, CO  80021

or to such other addresses as a party may designate pursuant to this notice
provision. Any notice given shall be deemed to have been received on the date on
which it is delivered personally, by courier service or by facsimile, or, if
mailed, on the third business day following the mailing thereof.

         14.5 Force Majeure. Neither party shall be liable for any breach of the
Agreement, other than any default in payment obligations, for any delay or
failure of performance resulting from any cause beyond such party's reasonable
control, including but not limited to the weather, civil disturbances, acts of
civil or military authorities, or acts of God.

         14.6 Severability. If any provision of this Agreement is held by a
court of competent jurisdiction to be unenforceable, such provision will be
changed and interpreted to accomplish the objectives of such provision to the
greatest extent possible under applicable law and the remaining provisions of
this Agreement will continue in full force and effect.

         14.7 Dispute Resolution. Each party agrees to negotiate in good faith
to resolve any dispute, claim or controversy arising out of or related to this
Agreement. In the event the parties are unable to resolve the dispute within
fifteen (15) days following the commencement of negotiations, each party shall
escalate the dispute through the appropriate levels of management, up to and
including the level of vice president, until the resolution of the issue is
achieved or the respective vice presidents cannot agree to a resolution of the
dispute. Unless otherwise agreed to by both parties, in no event shall the
escalation process exceed thirty (30) days. If, pursuant to the foregoing
dispute resolution procedure, the parties are unable to resolve the dispute,
claim or controversy, either party may institute an appropriate action in a
federal or state court having jurisdiction over the parties.

         14.8 Waiver. Any waiver or failure to enforce any provision of this
Agreement on one occasion will not be deemed a waiver of any other provision or
of such provision on any other occasion.

         14.9 Marketing Plan; Press Release. The parties shall cooperate with
each other so that each party may issue a press release concerning this
Agreement to be released simultaneously with the press release for the HA
Agreement, provided that each party must approve, in writing, such press release
prior to its release.

         14.10 Headings. The headings used for the sections of this Agreement
are for information purposes and convenience only and in no way define, limit,
construe or describe the scope or extent of the sections.

         14.11 Entire Agreement. This Agreement and its exhibits constitute the
entire agreement between the parties with regard to the subject matter hereof.
No oral or written representation that is not expressly contained in this
Agreement is binding on bConnected or Trac Medical. No amendment to this
Agreement or the Development Requirements shall be binding on either party
unless in writing and signed by both parties.

         14.12 Counterparts. This Agreement may be executed in separate
counterparts, each of which shall be deemed an original and all of which shall
be deemed one and the same instrument.

                                       15
<PAGE>

         IN WITNESS WHEREOF, the duly authorized representatives of bConnected
and Trac Medical have executed this Agreement as of the Effective Date.

BCONNECTED SOFTWARE, INC.                  TRAC MEDICAL SOLUTIONS, INC.

By: __________________________________     By: _________________________________

Name: ________________________________     Name: _______________________________

Title: _______________________________     Title: ______________________________

Date: ________________________________     Date: _______________________________

                                       16
<PAGE>

                                    EXHIBIT A

                       DESCRIPTION OF SOFTWARE; TRADEMARKS

bPIP Software is bConnected's Business Process Integration Platform which
includes the [ * * * * ].

Trac Medical Trademarks:

[to be provided]

bConnected Trademarks:

[to be provided]

Third Party Licenses.  [ * * * * ]

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       17
<PAGE>

                                    EXHIBIT B

                                   CARECERT ES

                                STATEMENT OF WORK

1.       Solution Architecture Services (services to commence for a period [ * *
         * * ] days when (i) the contract is signed, and (ii) receipt by [ * * *
         * ], and (iii) receipt by bConnected of the [ * * * * ], and (iv)
         receipt by bConnected of the current system functional specification
         for CareCert).

      o     Integration Plan: Developing a detailed specification and
            implementation plan for integrating with:

            o     [ * * * * ]

            o     [ * * * * ]- for the purpose of supporting digitally signed
                  information

      o     Install and Configure: Installing and configuring [ * * * * ]
            utilizing [ * * * * ]and an [ * * * * ]. Providing knowledge
            transfer for the CareCert development and support teams.

      o     Functionality: Create a functional solution for providing electronic
            form completion and for routing. [ * * * * ]

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

            o     [ * * * * ].

2.       Trac Medical Responsibilities

         o    Trac Medical will provide a current system functional
              specification.

         o    Trac Medical will provide documentation of the [ * * * * ]
              described in Section 1, sub section Functionality, bullet
              point 3.

         o    Trac Medical will provide electronic samples of [ * * * * ].

         o    Trac Medical will provide a list of current system
              enhancements that intended to be deployed in the current
              solution during CareCert ES development. Each enhancement will
              be described in a requirements document in enough detail as to
              allow for parallel development in CareCert ES. Any
              enhancements identified during Care Cert ES development will
              be communicated in like manner.

         o    Trac Medical will provide a [ * * * * ]

         o    Trac Medical will provide a [ * * * * ]. This interface will
              [ * * * * ].

         o    Trac Medical will provide a complete electronic copy of
              [ * * * * ]. This information will also be provided for any
              enhancements developed and deployed during development of
              CareCert ES. bConnected will also provide copies of all
              enhancements [ * * * * ].

         o    Trac Medical will provide a [ * * * * ].

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       18
<PAGE>

3.       Trac Medical Personnel

Trac Medical will provide access to key personnel including but not limited to
personnel knowledgeable and experienced in the following:

         [ * * * * ]- Personnel knowledgeable in the existing solution business
         process and in the best practice process as [ * * * * ]. In addition,
         business processes involved in current system enhancements will be
         communicated. In addition, Trac Medical will provide the services of
         the lead engineer for CareCert for a period of at least 5 consecutive
         days, for meetings in Colorado at bConnected, within the first 3 weeks
         following the signing of the licensing agreement, and will deliver to
         bConnected a full description of the functional specifications for
         CareCert and CareCert ES no later than one week following the signing
         of the licensing agreement.

         Current Solution Software Expertise - Personnel knowledgeable in the
         architecture and inner workings of the existing software solution.

4.       bConnected Personnel and Software

         bConnected will provide access to key personnel in order to provide
         knowledge transfer of the CareCert ES system. Through this knowledge
         transfer, Trac Medical will be able to support and extend the CareCert
         ES system using the bConnected tools. bConnected will provide those
         tools 45 days prior to final delivery of Care Cert ES.

         bConnected will provide Trac Medical personnel with access to
         bConnected's existing Bug Tracking software at no cost during the
         development of CareCert ES.

         bConnected will provide Trac Medical personnel with access to a Q/A
         environment hosted by bConnected and will keep the Q/A environment
         up-to-date with the latest development work ready for quality assurance
         review and testing.

5.       Major Milestones and Payment Schedule

         Trac Medical will receive invoices from bConnected at the end of each
         calendar month, detailing the actual hours worked on each stage of the
         project. Trac Medical agrees to pay each invoice within thirty (30)
         days after receipt of each invoice.

         Milestone 1: At end [ * * * * ]:

         1.       [ * * * * ]

         2.       [ * * * * ]

         3.       [ * * * * ] Estimated billing for period of $100,000.
                  Estimated hours [ * * * * ]

         Milestone 2: At end of [ * * * * ], bConnected will deliver [ * * * * ]
         - Estimated billing for period of $175,000. Estimated hours [ * * * * ]

         Milestone 3: When final stage is [ * * * * ] - [ * * * * ]. - Estimated
         billing for period of $100,000. Estimated hours [ * * * * ]

6.       Additional Definitions

         (a) CareCert Software. CareCert Software shall mean the CareCert
         solution, (including but not limited to the current CareCert API),
         using the stated technical architecture in such a manner that at a
         minimum contains all current functionalities, as of the effective date
         of the Agreement, of the CareCert solution. bConnected hereby agrees
         that any reverse engineering of the current CareCert Software that it
         undertakes pursuant to this Agreement shall not be deemed in any way as
         new product development by bConnected, and any new code associated with
         the reverse engineering phase of the overall project as described in
         this Exhibit B, except for bConnected Property including bConnected
         Derivatives, shall be considered to be CareCert Software owned in its
         entirety by Trac Medical and bConnected shall make all such CareCert
         Software available to Trac Medical on an "as requested" basis.

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       19
<PAGE>

         (b) CareCert ES. [ * * * * ]:

                  (i) [ * * * * ] which will mirror in functionality the
                  solution provide by the current CareCert solution including
                  but [ * * * * ].

                  (ii) [ * * * * ] current CareCert solution to [ * * * * ]
                  supplied by providers plus a [ * * * * ] to provide [ * * * *
                  ] processing and signing by physician. This [ * * * * ] with
                  the existing [ * * * * ].

         (c) It is further agreed that CareCert ES will, at a minimum, include
         the characteristics identified in Paragraph 1 (Functionality) of this
         Statement of Work.

7.       Acceptance. Upon completion of the Services provided under this
         Statement of Work, Client and Consultant shall meet on a mutually
         acceptable date to review the deliverables.

         IN WITNESS WHEREOF, pursuant and in accordance with the Development and
License Agreement between the parties hereto dated ______________________, the
parties have executed this Statement of Work as of this __the____ day of
January, 2004.

TRAC MEDICAL SOLUTIONS, INC.:              BCONNECTED SOFTWARE, INC.

By: __________________________________     By: _________________________________

Printed Name: ________________________     Printed Name: _______________________

Title: _______________________________     Title: ______________________________

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       20
<PAGE>

                                    EXHIBIT C

                                SUPPORT SERVICES

1. DEFINITIONS.

         "Designated Interface" means the contact person or group designated by
Trac Medical and agreed to by bConnected who will coordinate all Support
Services requests to bConnected.

         "Error" means a reproducible defect in the Supported Program when
operated on a Supported Environment, which causes the Supported Program not to
operate substantially in accordance with the Specifications.

         "Resolution" means a modification or workaround to the Supported
Program and/or documentation therefor and/or other information provided by
bConnected to Trac Medical intended to resolve an Error.

         "Support Hours" means 8:30 a.m. to 5:00 p.m. (Eastern Time), Monday
through Friday, excluding bConnected company holidays.

         "Supported Environment" means any hardware and operating system
platform which bConnected supports for use with the Supported Program.

         "Supported Program" means the current version of the Deliverables, for
which Trac Medical has paid the then-current Support Fees.

         "Update" means a subsequent release of the Deliverables which
bConnected generally makes available for licensees of the Deliverables at no
additional license fee other than shipping and handling charges. The term Update
includes all bug fixes and Error corrections to a Deliverable but Updates does
not include any release, option or future product which bConnected licenses
separately, including but not limited to any release of the Deliverables which
contains additional features or additional functionality. bConnected may charge
additional license and support fees for any such release, option or future
product.

2. SUPPORT SERVICES.

         2.1. Generally. Subject to the terms and conditions of this Agreement,
including but not limited to payment of the Support Fees, the Support Services
to be provided by bConnected to Trac Medical hereunder shall include: (a)
support services to diagnose, verify and correct or otherwise remedy any Errors
in the Supported Program and to answer technical questions or concerns related
to the Supported Program, and (b) any Updates of the Supported Program, as and
when made generally available to other bConnected licensees in bConnected's sole
discretion. Trac Medical agrees that all requests for Support Services shall
initially be delivered to bConnected via email. bConnected will acknowledge all
email inquiries it receives from Trac Medical and will track, record and archive
such messages. For all inquiries received by bConnected during its Support
Hours, bConnected will provide an initial response acknowledging the inquiry to
Trac Medical within four (4) business hours after its receipt of the inquiry.
bConnected will provide an initial response acknowledging inquiries received
after Support Hours by 11:00 a.m. MST the following business day. Thereafter,
bConnected shall use commercially reasonable efforts to provide a Resolution to
the Supported Program.

         2.2. Travel and Other Expenses. Support Services provided hereunder
shall be provided at bConnected's principal place of business, or at Trac
Medical's headquarters or offices at Trac Medical's expense, as determined in
bConnected's sole discretion. Should Trac Medical request that bConnected send
personnel to its offices to resolve any Error in the Supported Program, Trac
Medical shall pay bConnected's reasonable travel, meals and lodging expenses.
Under such circumstances, Trac Medical shall also pay actual costs for supplies
and other expenses reasonably incurred by bConnected, which are not of the sort
normally provided or covered by bConnected, provided that Trac Medical has
approved in advance the purchase of such supplies and other expenses. If Trac
Medical so requires, bConnected shall submit written evidence of each
expenditure to Trac Medical prior to receiving reimbursement of such costs and
expenses.

                                       21
<PAGE>

         2.3. Exceptions. bConnected will provide the Support Services only for
the most current release and the immediately preceding major release of the
Support Program. bConnected shall have no responsibility under this Agreement to
fix any Errors arising out of or related to the following causes: (a) Trac
Medical's modification or combination of the Supported Program (in whole or in
part); (b) use of the Supported Program in an environment other than a Supported
Environment; or (c) accident; unusual physical, electrical or electromagnetic
stress; neglect; misuse; failure or fluctuation of electric power, air
conditioning or humidity control; failure of media not furnished by bConnected;
excessive heating; fire and smoke damage; operation of the Supported Program
with other media and hardware, software or telecommunication interfaces not
meeting or not maintained in accordance with the manufacturer's specifications;
or causes other than ordinary use. Any corrections performed by bConnected for
such Errors shall be made, in bConnected's reasonable discretion, at
bConnected's then-current time and material charges. All Support Services
requested by Trac Medical outside the Support Hours will be provided by
bConnected at an additional cost to Trac Medical based on an hourly rate to be
determined by the parties.

3. TRAC MEDICAL RESPONSIBILITIES.

         3.1. Supervision and Management. Trac Medical is responsible for
undertaking the proper supervision, control and management of its use of the
Supported Programs, including, but not limited to: (a) assuring proper Supported
Environment configuration, Supported Programs installation and operating
methods; and (b) following industry standard procedures for the security of
data, accuracy of input and output, and back-up plans, including restart and
recovery in the event of hardware or software error or malfunction.

         3.2. Training. Trac Medical is responsible for proper training of all
appropriate personnel in the operation and use of the Supported Programs and
associated equipment.

         3.3. Designated Interface. Trac Medical shall designate the following
(2) individuals to serve as the Designated Interface with bConnected for the
Support Services provided hereunder: _______________________.

         3.4. Access to Personnel and Equipment. Trac Medical shall provide
bConnected with access to Trac Medical's personnel and its equipment during
Support Hours. This access must include the ability to remotely access the
equipment on which the Supported Programs are operating and to obtain the same
access to the equipment as those of Trac Medical's employees having the highest
privilege or clearance level. bConnected will inform Trac Medical of the
specifications of the remote access methods available and associated software
needed, and Trac Medical will be responsible for the costs and use of said
equipment.

                                       22
<PAGE>

                                    EXHIBIT D

              BCONNECTED CUSTOMERS AND EXISTING CARECERT CUSTOMERS

   bConnected Customers

       [ * * * * ]

Existing CareCert Customers

[ * Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

                                       23Exhibit 10.1

                             NOTE PURCHASE AGREEMENT

      THIS NOTE PURCHASE AGREEMENT (this "AGREEMENT") is made as of May __, 2004
by and between United Heritage Corporation, a Utah corporation (the "COMPANY"),
and the purchaser whose name and address is set forth on the signature page
hereto ("PURCHASER").

      WHEREAS, pursuant to that certain Subscription Application of the
Purchaser, substantially in the form of EXHIBIT A, the Company desires to sell
to the Purchaser and the Purchaser desires to purchase from the Company a
convertible promissory note in the aggregate principal amount set forth on the
signature page hereto, which shall be convertible into shares of the Company's
common stock, $.001 par value per share (the "COMMON STOCK"), on the terms and
subject to the conditions set forth in this Agreement and the other documents or
instruments contemplated hereby.

      NOW, THEREFORE, the parties hereto hereby agree as follows:

      Section 1. SALE AND ISSUANCE OF THE NOTE.

            Upon the terms and subject to the conditions contained in this
Agreement, the Company has authorized the sale and issuance (the "ISSUANCE") of
convertible promissory notes. At the Closing (as defined in SECTION 2.1), the
Company shall sell to the Purchaser, and the Purchaser shall purchase from the
Company, upon the terms set forth in this Agreement, one such convertible
promissory note, substantially in the form of EXHIBIT B attached hereto (the
"NOTE"), in the aggregate principal amount set forth on the signature page
hereto. The Company intends to enter into this same form of purchase agreement
with certain other investors and expects to complete sales of its convertible
promissory notes to them. The Purchaser's obligations hereunder are expressly
not subject to or conditioned on the purchase of notes by any or all of such
other investors.

            The Purchaser shall have the right and option, exercisable in its
sole discretion to convert the outstanding principal amount due hereunder into
that number of shares of Common Stock equal to the quotient obtained by dividing
(A) the outstanding principal amount of this Note by (B) $0.50. Additionally,
upon conversion, the Purchaser shall receive a warrant substantially in the form
of EXHIBIT C attached hereto (the "WARRANT") to purchase two shares of the
Company's Common Stock for every one share of Common Stock converted pursuant to
SECTION 2 of the Note, such Warrant providing for exercise prices of $0.75 per
share for half of the shares underlying the Warrant and $1.00 per share for the
remaining shares underlying the Warrant. The Purchaser shall only have the right
to convert, if the Company's shareholders approve, at the Company's Annual
Meeting to be held on March 23, 2004, or such other date determined by the
Company's Board of Directors, the issuance by the Company of Common Stock equal
to 20% or more of the Common Stock outstanding before the issuance for less than
the greater of book or market value of the stock.

                                       5
<PAGE>

      Section 2. THE CLOSING.

            2.1. The closing of the Issuance to the Purchaser (the "CLOSING")
shall take place, simultaneously with the execution and delivery of this
Agreement at the offices of Richardson & Patel, LLP, 10900 Wilshire Blvd., Suite
500, Los Angeles, CA 90024.

            2.2 At the Closing, the Company shall deliver to the Purchaser a
Note registered in the name of such Purchaser in the aggregate principal amount
to be purchased by such Purchaser pursuant to SECTION 1, against receipt by the
Company of a certified bank check or wire transfer in an aggregate amount equal
to the purchase price therefor as set forth on the signature page hereto. The
wire transfer shall be sent pursuant to the following instructions:

                Bank:          Comerica Bank of California
                               10900 Wilshire Blvd.
                               Los Angeles, CA 90024
                               (800) 888-3595

                ABA No.:       121137522
                Account No.:   1891937581
                Account Name:  Richardson & Patel, LLP Client Trust Account

      Section 3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

      The Company hereby represents and warrants to the Purchaser as follows:

            3.1. ORGANIZATION.

      The Company is duly organized, validly existing and in good standing under
the laws of the State of Utah and is qualified to conduct its business as a
foreign corporation in each jurisdiction where the failure to be so qualified
would have a material adverse effect on the Company.

            3.2. AUTHORIZATION OF AGREEMENT, ETC.

      The execution, delivery and performance by the Company of this Agreement
and the Note and each other document or instrument contemplated hereby or
thereby (collectively, the "FINANCING DOCUMENTS") have been duly authorized by
all requisite corporate action by the Company; and this Agreement and Note have
been duly executed and delivered by the Company. Each of the Financing
Documents, when executed and delivered by the Company, constitutes the valid and
binding obligation of the Company, enforceable against the Company in accordance
with its terms, subject to applicable bankruptcy, insolvency, reorganization,
fraudulent conveyance, moratorium or other similar laws affecting creditors'
rights and remedies generally, and subject as to enforceability to general
principles of equity (regardless of whether enforcement is sought in a
proceeding at law or in equity).

      Section 4. REPRESENTATIONS AND WARRANTIES OF THE PURCHASER.

      The Purchaser hereby represents and warrants to the Company as follows:

                                       6
<PAGE>

            4.1. AUTHORIZATION OF THE DOCUMENTS.

      Purchaser has all requisite power and authority (corporate or otherwise)
to execute, deliver and perform the Financing Documents to which it is a party
and the transactions contemplated thereby, and the execution, delivery and
performance by such Purchaser of the Financing Documents to which it is a party
have been duly authorized by all requisite action by such Purchaser and each
such Financing Document, when executed and delivered by the Purchaser,
constitutes a valid and binding obligation of such Purchaser, enforceable
against such Purchaser in accordance with its terms, subject to applicable
bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or
other similar laws affecting creditors' rights and remedies generally, and
subject, as to enforceability, to general principles of equity (regardless of
whether enforcement is sought in a proceeding at law or in equity).

      4.2. INVESTMENT REPRESENTATIONS.

      All of the representations and warranties of the Purchaser contained in
Sections 2 and 3 of that certain United Heritage Corporation Subscription
Application executed by the Purchaser, a copy of which is attached hereto as
EXHIBIT A, are incorporated herein by this reference and shall be true at the
Closing with the same effect as though made at such time.

      4.3 U.S.A. PATRIOT ACT REPRESENTATIONS

      (A) Purchaser represents, warrants and covenants that Purchaser:

            (i)(a) is subscribing for the Note for Purchaser's own account, own
risk and own beneficial interest, (b) is not acting as an agent, representative,
intermediary, nominee or in a similar capacity for any other person or entity,
nominee account or beneficial owner, whether a natural person or entity (each
such natural person or entity, an "UNDERLYING BENEFICIAL OWNER") and no
Underlying Beneficial Owner will have a beneficial or economic interest in the
Note, or the Common Stock, being purchased by Purchaser (whether directly or
indirectly, including without limitation, through any option, swap, forward or
any other hedging or derivative transaction), (c) if it is an entity, including,
without limitation, a fund-of-funds, trust, pension plan or any other entity
that is not a natural person (each, an "ENTITY"), has carried out thorough due
diligence as to and established the identities of such Entity's investors,
directors, officers, trustees, beneficiaries and grantors (to the extent
applicable, each a "RELATED PERSON" of such Entity), holds the evidence of such
identities, will maintain all such evidence for at least five years from the
date of Purchaser's resale or other disposition of the Note and all the Common
Stock, will request such additional information as the Company may require to
verify such identities as may be required by applicable law, and will make such
information available to the Company upon its request, and (d) does not have the
intention or obligation to sell, pledge, distribute, assign or transfer all or a
portion of the Note or the Common Stock to any Underlying Beneficial Owner or
any other person; OR (CHECK AND INITIAL ONE BOX)

                                       7
<PAGE>

            (ii)(a) is subscribing for the Note as a record owner and will not
have a beneficial ownership interest in the Note, (b) is acting as an agent,
representative, intermediary, nominee or in a similar capacity for one or more
Underlying Beneficial Owners (as defined in (A)(i)(a) above), and understands
and acknowledges that the representations, warranties and agreements made in the
Financing Documents are made by Purchaser with respect to both Purchaser and the
Underlying Beneficial Owner(s), (c) has all requisite power and authority from
the Underlying Beneficial Owner(s) to execute and perform the obligations under
the Subscription Agreement, (d) has carried out thorough due diligence as to and
established the identities of all Underlying Beneficial Owners (and, if an
Underlying Beneficial Owner is not a natural person, the identities of such
Underlying Beneficial Owner's Related Persons (to the extent applicable)), holds
the evidence of such identities, will maintain all such evidence for at least
five years from the date of Purchaser's resale or other disposition of all the
Note or Common Stock, and will make such information available to the Company
upon its request and (e) does not have the intention or obligation to sell,
pledge, distribute, assign or transfer all or a portion of the Note or Common
Stock to any person other than the Underlying Beneficial Owner(s).

      (B) Purchaser hereby represents and warrants that the proposed investment
in the Company that is being made on its own behalf or, if applicable, on behalf
of any Underlying Beneficial Owners does not directly or indirectly contravene
United States federal, state, local or international laws or regulations
applicable to Purchaser, including anti-money laundering laws (a "PROHIBITED
INVESTMENT").

      (C) Federal regulations and Executive Orders administered by the U.S.
Treasury Department's Office of Foreign Assets Control ("OFAC") prohibit, among
other things, the engagement in transactions with, and the provision of services
to, certain foreign countries, territories, entities and individuals. The lists
of OFAC prohibited countries, territories, persons and entities can be found on
the OFAC website at {www.treas.gov/ofac}. Purchaser hereby represents and
warrants that neither Purchaser nor, if applicable, any Underlying Beneficial
Owner or Related Person, is a country, territory, person or entity named on an
OFAC list, nor is Purchaser nor, if applicable, any Underlying Beneficial Owner
or Related Person, a natural person or entity with whom dealings are prohibited
under any OFAC regulations.

      (D) Purchaser represents and warrants that neither Purchaser nor, if
applicable, any Underlying Beneficial Owner or Related Person, is a senior
foreign political figure, or any immediate family member or close associate of a
senior foreign political figure within the meaning of, and applicable guidance
issued by the Department of the Treasury concerning, the U.S. Bank Secrecy Act
(31 U.S.C. ss.5311 et seq.), as amended, and any regulations promulgated
thereunder.

      (E) Purchaser agrees promptly to notify the Company should Purchaser
become aware of any change in the information set forth in paragraphs (A)
through (D).

      (F) Upon the written request from the Company, Purchaser agrees to provide
all information to the Company to enable the Company to comply with all
applicable anti-money laundering statutes, rules, regulations and policies,
including any policies applicable to a portfolio investment held or proposed to
be held by the Company. Purchaser understands and agrees that the Company may
release confidential information about Purchaser and, if applicable, any
Underlying Beneficial Owner(s) or Related Person(s) to any person, if the
Company, in its sole discretion, determines that such disclosure is necessary to
comply with applicable statutes, rules, regulations and policies.

                                       8
<PAGE>

      (G) Purchaser agrees to indemnify and hold harmless the Company, its
affiliates, their respective directors, officers, shareholders, employees,
agents and representatives (each, an "INDEMNITEE") from and against any and all
losses, liabilities, damages, penalties, costs, fees and expenses (including
legal fees and disbursements) (collectively, "DAMAGES") which may result,
directly or indirectly, from Purchaser's misrepresentations or misstatements
contained herein or breaches hereof relating to paragraphs (A) through (F).

      (H) Purchaser understands and agrees that, notwithstanding anything to the
contrary contained in any document (including any side letters or similar
agreements), if, following Purchaser's investment in the Company, it is
discovered that the investment is or has become a Prohibited Investment, such
investment may immediately be redeemed by the Company or otherwise be subject to
the remedies required by law, and Purchaser shall have no claim against any
Indemnitee for any form of Damages as a result of such forced redemption or
other action.

      4.4 RISK FACTORS. Purchaser acknowledges having received and read the Risk
Factors attached to the Subscription Application as EXHIBIT C (the "RISK
FACTORS"). Purchaser understands and accepts all of the risks set forth in the
Risk Factors.

      4.5 RESTRICTED STOCK. Purchaser understands and acknowledges that the
Common Stock and the Warrant Shares have not been, and when issued will not be,
registered with the Securities and Exchange Commission. Further, the Purchaser
understands and acknowledges that the certificates representing the Common Stock
and the Warrant Shares, if and when issued, shall bear a restrictive legend.

      4.6 ESCROW AGENT.

      Purchaser understands that the Company has appointed the law firm
Richardson & Patel, LLP to serve as the escrow agent (the "Escrow Agent") for
the transactions contemplated by this Agreement. The Escrow Agent is
concurrently acting as the Company's legal counsel and all fees and expenses
incurred by the Escrow Agent shall be paid by the Company. Such Purchaser agrees
and acknowledges that the duties of the Escrow Agent are only ministerial in
nature, and the Escrow Agent shall incur no liability except for bad faith. The
Escrow Agent is hereby instructed to receive (i) the purchase price of the
investment to be deposited by Purchaser at the Closing and held in an attorney
trust account designated by the Escrow Agent; and (ii) receive original or
copies of signature pages of this Agreement and the other Financing Documents.
At the Closing, the Escrow Agent shall (x) release the deposited funds along
with original or copies of the signature pages to this Agreement and the other
Financing Documents to the Company; and (y) copies of the signature pages to
this Agreement and the other Financing Documents to Purchaser.

                                       9
<PAGE>

      4.7 LEGAL COUNSEL.

      Purchaser understands that the law firm of Richardson and Patel, LLP and
its attorneys represent the Company and Purchaser has had the opportunity to
retain its own legal counsel in connection with transactions contemplated
herewith.

Section 5. REGISTRATION RIGHTS.

      5.1 REGISTRATION RIGHTS GRANTED. The Company hereby grants the following
registration rights to the Purchaser:

            (a) If the Company at any time proposes to register any of its
securities under the Securities Act of 1933, as amended (the "ACT") for sale to
the public, whether for its own account or for the account of other security
holders or both, except with respect to registration statements on Forms S-4,
S-8 or another form not available for registering the Registrable Securities for
sale to the public, provided the Registrable Securities are not otherwise
subject to an effective registration statement, the Company will give the
Purchaser written notice ("NOTICE OF REGISTRATION") to cause such Registrable
Securities to be included with the securities to be covered by the registration
statement proposed to be filed by the Company. In the event that any
registration pursuant to this Section 5.1(a) shall be, in whole or in part, an
underwritten public offering of Common Stock of the Company, the number of
shares of Registrable Securities to be included in such an underwriting may be
reduced by the managing underwriter if and to the extent that the Company and
the underwriter shall reasonably be of the opinion that such inclusion would
adversely affect the marketing of the securities to be sold by the Company
therein; provided, however, that the Company shall notify the Purchaser in
writing of any such reduction. "REGISTRABLE SECURITIES" means the number of
shares of the Company's Common Stock converted pursuant to Section 2 of the Note
and issuable upon exercise of the Warrant.

            (b) The Company shall file, or use its best efforts to file, a Form
SB-2 Registration Statement (or such other form that it is eligible to use) (a
"REGISTRATION STATEMENT") in order to register the issuance of the Registrable
Securities to the Purchaser under the Securities Act with the SEC within sixty
days after the last closing (the "FILING DATE"), and cause, or use its best
efforts to cause, such registration statement to be declared effective within
one hundred twenty days after the last Closing (the "EFFECTIVE DATE"). The
Company will include the number of shares of Common Stock in the aforedescribed
registration statement that is equal to the Registrable Securities (calculated
as of the date of filing).

            (c) The Company agrees not to enter into any acquisition agreements
which, upon consummation, would require the filing of a Form 8-K with audited
financial statements (a "MATERIAL ACQUISITION") until the Registration Statement
is declared effective, or 180 days after the last closing, whichever is first.
The Company also agrees that, after the Registration Statement is declared
effective, it will not enter into an agreement for any Material Acquisition for
a period of at least 60 days unless the Registration Statement is on Form S-3.

                                       10
<PAGE>

      5.2 REGISTRATION PROCEDURES. If and whenever the Company is required by
the provisions hereof to effect the registration of the Registrable Securities
under the Act, the Company will:

            (a) prepare and file with the SEC a registration statement with
respect to such securities and use its best efforts to cause such registration
statement to become and remain effective for the period of the distribution
contemplated thereby (determined as herein provided), and promptly provide to
the Purchaser copies of all filings and SEC letters of comment;

            (b) prepare and file with the SEC such amendments and supplements to
such registration statement and the prospectus used in connection therewith as
may be necessary to keep such registration statement effective until the earlier
date of when: (i) all Registrable Securities have been sold or (ii) all
Registrable Securities may be sold immediately without registration under the
Securities Act and without volume restrictions pursuant to Rule 144(k), as
determined by the counsel to the Company pursuant to a written opinion letter to
such effect, addressed and acceptable to the Company's transfer agent and the
affected Holders (the "Effectiveness Period");

            (c) furnish to the Purchaser such number of copies of the
registration statement and the prospectus included therein (including each
preliminary prospectus) as the Purchaser reasonably may request to facilitate
the public sale or disposition of the securities covered by such registration
statement;

            (d) register or qualify the Purchaser's Registrable Securities
covered by such registration statement under the securities or "blue sky" laws
of such jurisdictions as the Purchaser requests, provided, however, that the
Company shall not for any such purpose be required to qualify generally to
transact business as a foreign corporation in any jurisdiction where it is not
so qualified or to consent to general service of process in any such
jurisdiction;

            (e) list the Registrable Securities covered by such registration
statement with any securities exchange on which the Common Stock of the Company
is then listed;

      5.3 PROVISION OF DOCUMENTS. In connection with the registration hereunder,
the Purchaser will furnish to the Company in writing such information and
representation letters with respect to itself and the proposed distribution by
it as reasonably shall be necessary in order to assure compliance with federal
and applicable state securities laws.

      5.4 EXPENSES. All expenses incurred by the Company in complying with
Section 5, including, without limitation, all registration and filing fees,
printing expenses, fees and disbursements of counsel and independent public
accountants for the Company, fees and expenses (including reasonable counsel
fees) incurred in connection with complying with state securities or "blue sky"
laws, fees of the NASD, transfer taxes, fees of transfer agents and registrars,
fees of, and disbursements incurred by, and costs of insurance are called
"REGISTRATION EXPENSES". All underwriting discounts and selling commissions
applicable to the sale of Registrable Securities, including any fees and
disbursements of any special counsel to the Purchaser beyond those included in
Registration Expenses, are called "SELLING EXPENSES." The Company shall be
responsible for all Registration Expenses. All Selling Expenses in connection
with each registration statement shall be borne by Purchaser.

                                       11
<PAGE>

      5.5 INDEMNIFICATION.

            (a) In the event of a registration of any Registrable Securities
under the Act pursuant to Section 5, the Company will indemnify and hold
harmless the Purchaser, and its officers, directors and each other person, if
any, who controls the Purchaser within the meaning of the Securities Act,
against any losses, claims, damages or liabilities, joint or several, to which
the Purchaser, or such persons may become subject under the Securities Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in any registration statement
under which such Registrable Securities were registered under the Securities Act
pursuant to Section 5, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading,
and will reimburse the Purchaser, and each such person for any reasonable legal
or other expenses incurred by them in connection with investigating or defending
any such loss, claim, damage, liability or action; provided, however, that the
Company will not be liable in any such case if and to the extent that any such
loss, claim, damage or liability arises out of or is based upon an untrue
statement or alleged untrue statement or omission or alleged omission so made in
conformity with information furnished by the Purchaser or any such person in
writing specifically for use in any such document.

            (b) In the event of a registration of the Registrable Securities
under the Securities Act pursuant to Section 5, the Purchaser will indemnify and
hold harmless the Company, and its officers, directors and each other person, if
any, who controls the Company within the meaning of the Securities Act, against
all losses, claims, damages or liabilities, joint or several, to which the
Company or such persons may become subject under the Securities Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in the registration statement
under which such Registrable Securities were registered under the Securities Act
pursuant to Section 5, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading,
and will reimburse the Company and each such person for any reasonable legal or
other expenses incurred by them in connection with investigating or defending
any such loss, claim, damage, liability or action, provided, however, that the
Purchaser will be liable in any such case if and only to the extent that any
such loss, claim, damage or liability arises out of or is based upon an untrue
statement or alleged untrue statement or omission or alleged omission so made in
conformity with information furnished in writing to the Company by the Purchaser
specifically for use in any such document.

                                       12
<PAGE>

            (c) Promptly after receipt by an indemnified party hereunder of
notice of the commencement of any action, such indemnified party shall, if a
claim in respect thereof is to be made against the indemnifying party hereunder,
notify the indemnifying party in writing thereof, but the omission so to notify
the indemnifying party shall not relieve it from any liability which it may have
to such indemnified party other than under this Section 5.5(c) and shall only
relieve it from any liability which it may have to such indemnified party under
this Section 5.5(c) if and to the extent the indemnifying party is prejudiced by
such omission. In case any such action shall be brought against any indemnified
party and it shall notify the indemnifying party of the commencement thereof,
the indemnifying party shall be entitled to participate in and, to the extent it
shall wish, to assume and undertake the defense thereof with counsel
satisfactory to such indemnified party, and, after notice from the indemnifying
party to such indemnified party of its election so to assume and undertake the
defense thereof, the indemnifying party shall not be liable to such indemnified
party under this Section 5.5(c) for any legal expenses subsequently incurred by
such indemnified party in connection with the defense thereof; if the
indemnified party retains its own counsel, then the indemnified party shall pay
all fees, costs and expenses of such counsel, provided, however, that, if the
defendants in any such action include both the indemnified party and the
indemnifying party and the indemnified party shall have reasonably concluded
that there may be reasonable defenses available to it which are different from
or additional to those available to the indemnifying party or if the interests
of the indemnified party reasonably may be deemed to conflict with the interests
of the indemnifying party, the indemnified parties shall have the right to
select one separate counsel and to assume such legal defenses and otherwise to
participate in the defense of such action, with the reasonable expenses and fees
of such separate counsel and other expenses related to such participation to be
reimbursed by the indemnifying party as incurred.

            (d) In order to provide for just and equitable contribution in the
event of joint liability under the Securities Act in any case in which either
(i) the Purchaser, or any controlling person of the Purchaser, makes a claim for
indemnification pursuant to this Section 5.5 but it is judicially determined (by
the entry of a final judgment or decree by a court of competent jurisdiction and
the expiration of time to appeal or the denial of the last right of appeal) that
such indemnification may not be enforced in such case notwithstanding the fact
that this Section 5.5 provides for indemnification in such case, contribution
under the Securities Act may be required on the part of the Purchaser or
controlling person of the Purchaser in circumstances for which indemnification
is provided under this Section 5.5; then, and in each such case, the Company and
the Purchaser will contribute to the aggregate losses, claims, damages or
liabilities to which they may be subject (after contribution from others) in
such proportion so that the Purchaser is responsible only for the portion
represented by the percentage that the public offering price of its securities
offered by the registration statement bears to the public offering price of all
securities offered by such registration statement, provided, however, that, in
any such case, (A) the Purchaser will not be required to contribute any amount
in excess of the public offering price of all such securities offered by it
pursuant to such registration statement; and (B) no person or entity guilty of
fraudulent misrepresentation (within the meaning of Section 10(f) of the Act)
will be entitled to contribution from any person or entity who was not guilty of
such fraudulent misrepresentation.

                                       13
<PAGE>

      Section 6. BROKERS AND FINDERS.

      The Company shall not be obligated to pay any commission, brokerage fee or
finder's fee based on any alleged agreement or understanding between the
Purchaser and a third person in respect of the transactions contemplated hereby.
The Purchaser hereby agrees to indemnify the Company against any claim by any
third person for any commission, brokerage or finder's fee or other payment with
respect to this Agreement or the transactions contemplated hereby based on any
alleged agreement or understanding between the Purchaser and such third person,
whether express or implied from the actions of the Purchaser.

      Section 7. SUCCESSORS AND ASSIGNS.

      This Agreement shall bind and inure to the benefit of the Company, the
Purchaser and their respective successors and assigns.

      Section 8. ENTIRE AGREEMENT.

      This Agreement and the other writings and agreements referred to in this
Agreement or delivered pursuant to this Agreement contain the entire
understanding of the parties with respect to the subject matter hereof and
supersede all prior agreements and understandings among the parties with respect
thereto.

      Section 9. NOTICES.

      All notices, demands and requests of any kind to be delivered to any party
in connection with this Agreement shall be in writing and shall be deemed to
have been duly given if personally delivered or if sent by an
internationally-recognized overnight courier or by registered or certified mail,
return receipt requested and postage prepaid, addressed as follows:

            (a)   if to the Company, to:

                                    United Heritage Corporation
                                    2 Caddo Street
                                    Cleburne, Texas 76031
                                    Telecopier: (817) 641-3683
                                    Attention:  Walter Mize

                                    with a copy to:

                                    Richardson & Patel, LLP
                                    10900 Wilshire Blvd., Suite 500
                                    Los Angeles, CA 90024
                                    Telecopier: (310) 208-1154
                                    Attention: Erick Richardson, Esq.

            (b)   if to any Purchaser, to:

                                    the address of such Purchaser set forth on
                                    the signature page hereto;

                                       14
<PAGE>

or to such other address as the party to whom notice is to be given may have
furnished to the other parties to this Agreement in writing in accordance with
the provisions of this SECTION 9. Any such notice or communication shall be
deemed to have been received (i) in the case of personal delivery, on the date
of such delivery, (ii) in the case of an internationally-recognized overnight
courier, on the next business day after the date when sent and (iii) in the case
of mailing, on the third business day following that on which the piece of mail
containing such communication is posted.

      Section 10. AMENDMENTS.

      This Agreement may not be modified or amended, or any of the provisions of
this Agreement waived, except by written agreement of the Company and the
Purchaser.

      Section 11. GOVERNING LAW; WAIVER OF JURY TRIAL.

            (c) All questions concerning the construction, interpretation and
validity of this Agreement shall be governed by and construed and enforced in
accordance with the domestic laws of the State of Texas without giving effect to
any choice or conflict of law provision or rule (whether in the State of Texas
or any other jurisdiction) that would cause the application of the laws of any
jurisdiction other than the State of Texas. In furtherance of the foregoing, the
internal law of the State of Texas will control the interpretation and
construction of this Agreement, even if under such jurisdiction's choice of law
or conflict of law analysis, the substantive law of some other jurisdiction
would ordinarily or necessarily apply.

            (d) BECAUSE DISPUTES ARISING IN CONNECTION WITH COMPLEX FINANCIAL
TRANSACTIONS ARE MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN EXPERIENCED AND
EXPERT PERSON AND THE PARTIES WISH APPLICABLE LAWS TO APPLY (RATHER THAN
ARBITRATION RULES), THE PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED BY A
JUDGE APPLYING SUCH APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST COMBINATION
OF THE BENEFITS OF THE JUDICIAL SYSTEM AND OF ARBITRATION, THE PARTIES HERETO
WAIVE ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BROUGHT TO
ENFORCE OR DEFEND ANY RIGHTS OR REMEDIES UNDER THIS AGREEMENT OR ANY DOCUMENTS
RELATED HERETO.

      Section 12. SUBMISSION TO JURISDICTION.

      Any legal action or proceeding with respect to this Agreement or the other
Financing Documents may be brought in the courts of the State of Texas and the
United States of America located in Cleburne, Texas and, by execution and
delivery of this Agreement, the Company hereby accepts for itself and in respect
of its property, generally and unconditionally, the jurisdiction of the
aforesaid courts. The Purchaser hereby irrevocably waives, in connection with
any such action or proceeding, any objection, including, without limitation, any
objection to the venue or based on the grounds of forum non conveniens, which it
may now or hereafter have to the bringing of any such action or proceeding in
such respective jurisdictions. The Purchaser hereby irrevocably consents to the
service of process of any of the aforementioned courts in any such action or
proceeding by the mailing of copies thereof by registered or certified mail,
postage prepaid, to it at its address as set forth herein.

                                       15
<PAGE>

      Section 13. SEVERABILITY.

      It is the desire and intent of the parties that the provisions of this
Agreement be enforced to the fullest extent permissible under the law and public
policies applied in each jurisdiction in which enforcement is sought.
Accordingly, in the event that any provision of this Agreement would be held in
any jurisdiction to be invalid, prohibited or unenforceable for any reason, such
provision, as to such jurisdiction, shall be ineffective, without invalidating
the remaining provisions of this Agreement or affecting the validity or
enforceability of such provision in any jurisdiction. Notwithstanding the
foregoing, if such provision could be more narrowly drawn so as not be invalid,
prohibited or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so narrowly drawn, without invalidating the remaining
provisions of this Agreement or affecting the validity or enforceability of such
provision in any other jurisdiction.

      Section 14. INDEPENDENCE OF AGREEMENTS, COVENANTS, REPRESENTATIONS AND
WARRANTIES.

      All agreements and covenants hereunder shall be given independent effect
so that if a certain action or condition constitutes a default under a certain
agreement or covenant, the fact that such action or condition is permitted by
another agreement or covenant shall not affect the occurrence of such default,
unless expressly permitted under an exception to such covenant. In addition, all
representations and warranties hereunder shall be given independent effect so
that if a particular representation or warranty proves to be incorrect or is
breached, the fact that another representation or warranty concerning the same
or similar subject matter is correct or is not breached will not affect the
incorrectness of or a breach of a representation and warranty hereunder. The
exhibits and any schedules attached hereto are hereby made part of this
Agreement in all respects.

      Section 15. COUNTERPARTS.

      This Agreement may be executed in any number of counterparts, and each
such counterpart of this Agreement shall be deemed to be an original instrument,
but all such counterparts together shall constitute but one agreement. Facsimile
counterpart signatures to this Agreement shall be acceptable and binding.

      Section 16. HEADINGS.

      The section and paragraph headings contained in this Agreement are for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.

      Section 17. PREPARATION OF AGREEMENT.

      The Company prepared this Agreement and the Financing Documents solely on
its behalf. Each party to this Agreement acknowledges that: (i) the party had
the advice of, or sufficient opportunity to obtain the advice of, legal counsel
separate and independent of legal counsel for any other party hereto; (ii) the
terms of the transactions contemplated by this Agreement are fair and reasonable
to such party; and (iii) such party has voluntarily entered into the
transactions contemplated by this Agreement without duress or coercion. Each
party further acknowledges that such party was not represented by the legal
counsel of any other party hereto in connection with the transactions
contemplated by this Agreement, nor was he or it under any belief or
understanding that such legal counsel was representing his or its interests.
Each party agrees that no conflict, omission or ambiguity in this Agreement, or
the interpretation thereof, shall be presumed, implied or otherwise construed
against any other party to this Agreement on the basis that such party was
responsible for drafting this Agreement.

                                    * * * * *

                                       16
<PAGE>

      IN WITNESS WHEREOF, each of the undersigned has duly executed this Note
Purchase Agreement as of the date first written above.

                                        COMPANY:

                                        UNITED HERITAGE CORPORATION

                                        By: ________________________________
                                            Name:  Walter Mize
                                            Title:  President

PURCHASER:

______________________________              ________________________________
Name of Purchaser (Individual or            Name of Individual representing
  Institution)                              Purchaser (if an Institution)

______________________________              ________________________________
Title of Individual representing            Signature of Individual Purchaser or
  Purchaser (if an Institution)             Individual representing Purchaser

                                        Address:

                                        ________________________________

                                        Telephone:

                                        ________________________________

                                        Telecopier:

                                        ________________________________

NOTE PRINCIPAL AMOUNT
---------------------
$

                                       17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}]]